Avanos Medical (NYSE:AVNS) Releases Earnings Results, Beats Expectations By $0.03 EPS

Avanos Medical (NYSE:AVNS) released its quarterly earnings results on Wednesday. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03, Zacks reports. The business had revenue of $179.60 million for the quarter, compared to analysts’ expectations of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Avanos Medical updated its FY 2025 guidance to 1.050-1.250 EPS.

Avanos Medical Price Performance

Shares of NYSE:AVNS opened at $15.72 on Thursday. The business’s fifty day moving average price is $16.15 and its two-hundred day moving average price is $19.73. The stock has a market cap of $722.49 million, a PE ratio of 46.24 and a beta of 0.98. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. Avanos Medical has a one year low of $14.40 and a one year high of $25.36.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.